Xiaoying Sun to Aged, 80 and over
This is a "connection" page, showing publications Xiaoying Sun has written about Aged, 80 and over.
Connection Strength
0.013
-
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med. 2014 Jan 23; 370(4):311-21.
Score: 0.013